Enterade
Sponsors
Dana-Farber Cancer Institute, Sonoma State University, PATH, Virginia Commonwealth University
Conditions
Environmental Enteric DysfunctionHealthyMultiple MyelomaNon-Hodgkin's LymphomaStunting
Unknown Phase
A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma
CompletedNCT02919670
Start: 2016-10-31End: 2020-07-31Updated: 2023-03-16
Beverage Hydration Index of Commercial Therapeutic Beverages
CompletedNCT03262597
Start: 2017-02-17End: 2017-04-14Updated: 2018-03-07
Safety, Acceptability, and Feasibility of Enterade®
TerminatedNCT03782272
Start: 2019-02-26End: 2020-06-30Updated: 2021-02-04
Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh
CompletedNCT05291559
Start: 2022-07-18End: 2022-09-07Updated: 2022-09-10